PRODUCTS & INNOVATION
Robert Ford was named Abbott's President and Chief Operating Officer, with responsibility for all of the company's operating businesses, in October 2018. He was appointed to Abbott's Board of Directors in November 2019 and will succeed Miles D. White as Chief Executive Officer on March 31, 2020.
Previously Mr. Ford served as Executive Vice President, Medical Devices, where he led our Diabetes Care, Cardiovascular and Neuromodulation businesses. He joined Abbott's Diagnostics division in 1996 as a Business Unit Manager in Diabetes Care. He subsequently held various positions of increasing responsibility for Abbott's Diagnostics, Nutrition and Diabetes Care businesses.
Mr. Ford earned a bachelor's degree from Boston College and a master's degree in business administration from UC Berkeley, Haas School of Business.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimized for your specific screen size.
Links which take you out of Abbott worldwide websites are not under the control of Abbott, and Abbott is not responsible for the contents of any such site or any further links from such site. Abbott is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott.
The website that you have requested also may not be optimized for your screen size.